Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

1.3%

1 terminated/withdrawn out of 77 trials

Success Rate

96.0%

+9.5% vs industry average

Late-Stage Pipeline

35%

27 trials in Phase 3/4

Results Transparency

8%

2 of 24 completed trials have results

Key Signals

7 recruiting2 with results

Enrollment Performance

Analytics

Phase 4
21(32.3%)
N/A
15(23.1%)
Phase 1
12(18.5%)
Phase 2
9(13.8%)
Phase 3
6(9.2%)
Early Phase 1
2(3.1%)
65Total
Phase 4(21)
N/A(15)
Phase 1(12)
Phase 2(9)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (77)

Showing 20 of 77 trials
NCT07727642Not ApplicableRecruiting

Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma

Role: lead

NCT03881787Phase 1Completed

Clinical Trial to Evaluate Pharmacokinetics,Safety and Immunogenicity of Single Injection of CDP1 to Healthy Volunteers Compared to Erbitux

Role: collaborator

NCT07631897Phase 4Not Yet Recruiting

Comparative Trial Between Ainuovirine(ANV)/Lamivudine(3TC)/Tenofovir(TDF) and Efavirenz(EFV)/Lamivudine/Tenofovir Regimens

Role: lead

NCT06940375Completed

Incidence of Liver Disease-Related Outcomes in People With HIV

Role: lead

NCT07608172Not ApplicableNot Yet Recruiting

Short-Course Regimens for DS-PTB in AIDS Patients

Role: lead

NCT07585461Not ApplicableNot Yet Recruiting

Enhanced Treatment Strategy for Disseminated MAC Infection in HIV Patients: A Randomized Controlled Trial

Role: lead

NCT07579247Phase 1Not Yet Recruiting

Efficacy and Safety of Immune Checkpoint Inhibitors for Refractory Opportunistic Infections in AIDS

Role: lead

NCT07565623Not ApplicableNot Yet Recruiting

Prevention of AIDS With Opportunistic Infection Paradoxical IRIS

Role: lead

NCT07323173Phase 1Recruiting

A Phase I Study to Assess LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus

Role: collaborator

NCT07526363Not Yet Recruiting

Real-world Cohort Study of Antiretroviral Therapy in HIV Patients With Opportunistic Infections

Role: lead

NCT06085690Not ApplicableRecruiting

Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement Science

Role: collaborator

NCT07191951Recruiting

Shanghai Clinical Cohort - Adrenal Disease

Role: collaborator

NCT04669496Phase 2Active Not Recruiting

Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

Role: collaborator

NCT03093688Phase 1Recruiting

Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor

Role: lead

NCT06926569Not ApplicableNot Yet Recruiting

Single High-dose of Liposomal Amphotericin B in Combination With B/F/TAF for HIV/AIDS-associated Talaromycosis

Role: lead

NCT05431621Completed

Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers

Role: collaborator

NCT06768697Early Phase 1Not Yet Recruiting

Safety and Immunogenicity Evaluation of the Recombinant Flagellin Protein Adjuvant

Role: lead

NCT05278988Phase 4Completed

A Study of Ultrashort PRS Regimen V in the Treatment of MDR-TB

Role: collaborator

NCT03393936Phase 1Terminated

Safety and Efficacy of CCT301 CAR-T in Adult Subjects With Recurrent or Refractory Stage IV Renal Cell Carcinoma

Role: collaborator

NCT06470386Phase 2Not Yet Recruiting

The Efficacy and Safety of Alverine in the Treatment of Portal Hypertension in Patients With Liver Cirrhosis

Role: collaborator